Bonos de TAK
A continuación, encontrará la lista de bonos de corporativos Takeda Pharmaceutical Company Limited. Los inversores suelen optar por los bonos de empresa debido a su mayor estabilidad en tiempos de volatilidad del mercado. Estudie los precios, los rendimientos y otras estadísticas para encontrar una inversión fiable.
Símbolo | YTM % | Precio % | Cupón % | Fecha de vencimiento | Imp. pendiente | Valor nominal | Imp. mín. denom. | Emisor |
|---|---|---|---|---|---|---|---|---|
 TKPH5841810Takeda Pharmaceutical Company Limited 5.8% 05-JUL-2064 | 5,40% | 107,75% | 5,80% | 2064-07-05 | 500 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5841809Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2054 | 5,28% | 106,20% | 5,65% | 2054-07-05 | 600 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TTKPH4369980Baxalta Incorporated 5.25% 23-JUN-2045 | 5,17% | 101,07% | 5,25% | 2045-06-23 | 500,407 M USD | 1.000,00 USD | 2.000,00 USD | Baxalta, Inc. |
| TKPH5841808Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2044 | 5,16% | 106,40% | 5,65% | 2044-07-05 | 800 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5010047Takeda Pharmaceutical Company Limited 3.175% 09-JUL-2050 | 4,91% | 72,59% | 3,18% | 2050-07-09 | 2 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5010046Takeda Pharmaceutical Company Limited 3.025% 09-JUL-2040 | 4,90% | 78,58% | 3,03% | 2040-07-09 | 1,5 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5010048Takeda Pharmaceutical Company Limited 3.375% 09-JUL-2060 | 4,86% | 71,57% | 3,38% | 2060-07-09 | 1 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5841807Takeda Pharmaceutical Company Limited 5.3% 05-JUL-2034 | 4,69% | 104,85% | 5,30% | 2034-07-05 | 1,1 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TTKPH4370840Baxalta Incorporated 4.0% 23-JUN-2025 | 4,53% | 99,48% | 4,00% | 2025-06-23 | 800,169 M USD | 1.000,00 USD | 2.000,00 USD | Baxalta, Inc. |
| TKPH4770188Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 | 4,29% | 102,75% | 5,00% | 2028-11-26 | 1,727 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5010045Takeda Pharmaceutical Company Limited 2.05% 31-MAR-2030 | 4,24% | 89,18% | 2,05% | 2030-03-31 | 2,5 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| UUS82481LAD1SHIRE ACQUIST.I.IE 16/26 | 4,05% | 98,35% | 3,20% | 2026-09-23 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Shire Acquisitions Investments Ireland DAC |
| TKDBTAKEDA PHARMA. 20/40 | 3,75% | 78,67% | 2,00% | 2040-07-09 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS219734964TAKEDA PHARMA. 20/32 | 3,28% | 86,81% | 1,38% | 2032-07-09 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS184344939TAKEDA PHARMA.18/30 REGS | 3,21% | 98,81% | 3,00% | 2030-11-21 | 1,5 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS219734859TAKEDA PHARMA. 20/29 | 3,03% | 90,91% | 1,00% | 2029-07-09 | 850 M EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS184344912TAKEDA PHARMA. 18/26 REGS | 3,01% | 98,40% | 2,25% | 2026-11-21 | 1,5 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS219734832TAKEDA PHARMA. 20/27 | 2,90% | 94,21% | 0,75% | 2027-07-09 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| TKPH4770186Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 | 0,96% | 116,57% | 5,00% | 2028-11-26 | 22,685 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH4770187Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 | — | — | 5,00% | 2028-11-26 | 22,685 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| SSHPG4260178Baxalta Incorporated 4.0% 23-JUN-2025 | — | — | 4,00% | 2025-06-23 | 303 K USD | 1.000,00 USD | 2.000,00 USD | Baxalta, Inc. |